medigraphic.com

2018, Number 3

<< Back Next >>

Rev Hosp Jua Mex 2018; 85 (3)

Kawasaki disease

Gil MG, Nieto ZN, León CA, Hernández VZ

Language: Spanish
References: 14
Page: 154-158
PDF size: 204.64 Kb.


ABSTRACT

Kawasaki disease (KD) is a febrile disease in childhood, characterized by an acute systemic vasculitis of small and medium vessels, with predilection of the coronary arteries. It is the leading cause of heart disease in developing countries. The natural history, treatment and complications are well described. However, the etiology still remains unknown, hindering efforts to develop a diagnostic test and specific treatments.


REFERENCES

  1. Son MBF, Newburger JW, Kawasaki disease. Pediatr Rev 2018; 39: 78-90.

  2. Garrido-García LM, Soto-Blanquel JL, Espinosa-Rosales FJ. Enfermedad de Kawasaki: cuadro clínico, exámenes de laboratorio y lesiones coronarias. Acta Pediatr Méx 2015; 36: 314-21.

  3. García-Rodríguez F, Flores-Pineda AJ, Villareal-Treviño AV, Salinas-Encinas DR, Lara-Herrera PB, Maldonado-Velásquez MR y cols. Enfermedad de Kawasaki en un hospital pediátrico en México. Bol Med Hosp Infant Mex 2016; 73: 166-73.

  4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on Cardiovascular disease in the young. American Heart Association. Circulation 2004; 110: 2747-71.

  5. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease. 5th edition). Pediatr Int 2005; 47: 232-4.

  6. Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheuma Dis 2018; 21(1): 36-44.

  7. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135(17): e927-99.

  8. Rowley AH. The complexities of the diagnosis and management of Kawasaki disease. Infect Dis Clin North Am 2015; 29: 525-537. PMID: 26154665 doi: 10.1016/j.idc.2015.05.006

  9. Veiga PA, Pieroni D, Baier W, Feld LG. Association of Kawasaki disease and interstitial nephritis. Pediatric Nephrology 1992; 6(5): 421-3.

  10. Singh S, Gupta A, Jindal AK, Gupta A, Suri D, Rawat A, Vaidya PC, Singh M. Pulmonary presentation of Kawasaki disease-A diagnostic challenge. Pediatr Pulmonol 2018; 53: 103-7.

  11. Agarwal S, Gupta A, Suri D, Rawat A, Singh S. Proximal muscle weakness in a child with Kawasaki disease. Indian J Pediatr 2015; 82: 866.

  12. Wright H, Waddington C, Geddes J, Newburger JW, Burgner D. Facial nerve palsy complicating Kawasaki disease. Pediatrics 2008; 122: e783-5.

  13. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 2002; 324(7351): 1424-5.

  14. Diagnóstico y tratamiento de la Enfermedad de Kawasaki. En el primer, segundo y tercer nivel de atención. (Síndrome Mucocutáneo linfonodular). Catálogo Maestro de Guías de Práctica Clínica: IMSS-395-10. http://imss.gob.mx/profesionales-salud/gpc




2020     |     www.medigraphic.com